These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1361106)

  • 21. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas.
    Wajjwalku W; Nakamura S; Hasegawa Y; Miyazaki K; Satoh Y; Funahashi H; Matsuyama M; Takahashi M
    Jpn J Cancer Res; 1992 Jul; 83(7):671-5. PubMed ID: 1381340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of protooncogene bcl-2 in thyroid tumors].
    Zhu J; Chen Y; Xue H
    Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):829-31. PubMed ID: 9275533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical application of human telomerase reverse transcriptase gene expression in thyroid follicular tumors by fine-needle aspirations using in situ hybridization.
    Kammori M; Nakamura K; Hashimoto M; Ogawa T; Kaminishi M; Takubo K
    Int J Oncol; 2003 May; 22(5):985-91. PubMed ID: 12684663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas.
    Terrier P; Sheng ZM; Schlumberger M; Tubiana M; Caillou B; Travagli JP; Fragu P; Parmentier C; Riou G
    Br J Cancer; 1988 Jan; 57(1):43-7. PubMed ID: 3348948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.
    Vitagliano D; Portella G; Troncone G; Francione A; Rossi C; Bruno A; Giorgini A; Coluzzi S; Nappi TC; Rothstein JL; Pasquinelli R; Chiappetta G; Terracciano D; Macchia V; Melillo RM; Fusco A; Santoro M
    Oncogene; 2006 Aug; 25(39):5467-74. PubMed ID: 16785999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.
    Czyz W; Joensuu H; Pylkkänen L; Klemi PJ
    J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of the follicular variant of papillary thyroid carcinoma. Significance of immunohistochemistry].
    Guyétant S; Michalak S; Valo I; Saint-André JP
    Ann Pathol; 2003 Feb; 23(1):11-20. PubMed ID: 12743496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
    Volm M; Kästel M; Mattern J; Efferth T
    Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HGF/C-MET system pathways in benign and malignant histotypes of thyroid nodules: an immunohistochemical characterization.
    Ruggeri RM; Vitarelli E; Barresi G; Trimarchi F; Benvenga S; Trovato M
    Histol Histopathol; 2012 Jan; 27(1):113-21. PubMed ID: 22127603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.
    Di Renzo MF; Olivero M; Ferro S; Prat M; Bongarzone I; Pilotti S; Belfiore A; Costantino A; Vigneri R; Pierotti MA
    Oncogene; 1992 Dec; 7(12):2549-53. PubMed ID: 1334253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
    Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical analysis of expression of nm23-H1/nucleoside diphosphate kinase in human thyroid carcinomas: lack of correlation between its expression and lymph node metastasis.
    Luo W; Matsuo K; Nagayama Y; Urano T; Furukawa K; Takeshita A; Nakayama T; Yokoyama N; Yamashita S; Izumi M
    Thyroid; 1993; 3(2):105-9. PubMed ID: 8396479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure and expression of nuclear oncogenes in multi-stage thyroid tumorigenesis.
    Wyllie FS; Lemoine NR; Williams ED; Wynford-Thomas D
    Br J Cancer; 1989 Oct; 60(4):561-5. PubMed ID: 2803926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ras oncogene mutations in benign and malignant thyroid neoplasms.
    Karga H; Lee JK; Vickery AL; Thor A; Gaz RD; Jameson JL
    J Clin Endocrinol Metab; 1991 Oct; 73(4):832-6. PubMed ID: 1890154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of N-myc immunoreactivity in medullary thyroid carcinoma.
    Roncalli M; Viale G; Grimelius L; Johansson H; Wilander E; Alfano RM; Springall D; Battezzati PM; Polak JM; Coggi G
    Cancer; 1994 Jul; 74(1):134-41. PubMed ID: 7911734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of c-myc mRNA as an aid in histologic differentiation of adenoma from well differentiated adenocarcinoma in the stomach.
    Tatsuta M; Iishi H; Baba M; Nakaizumi A; Uehara H; Taniguchi H
    Cancer; 1994 Apr; 73(7):1795-9. PubMed ID: 8137202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High c-myc protein expression in benign colorectal lesions correlates with the degree of dysplasia.
    Pavelic ZP; Pavelic L; Kuvelkar R; Gapany SR
    Anticancer Res; 1992; 12(1):171-5. PubMed ID: 1567165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.